No Detail Found!

In Vitro effect of New Antibiotics against Clinical Isolates of Salmonella Typhi.

Author(s)
Nasrullah Malik Department of Pathology, Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Mamoon Ahmed Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan
Abstract
Objective: To determine the in vitro disk diffusion and MIC patterns of the therapeutic alternatives for Salmonella Typhi. Study Design: A cross-sectional study. Place and Duration of Study: Armed Forces Institute of Pathology, Rawalpindi, from June 2011 to May 2013. Methodology: Clinical samples were collected from suspected cases of Salmonella infections. Culture was obtained on standard media. Suspected Salmonella colonies were tested by API 20E and confirmed by serology. The isolates were tested for resistance to various antibiotics by Kirby-Bauer disc diffusion method. MIC was done on MDR and ciprofloxacin intermediate or resistant cases by E-strips for selected antibiotics. Results: One hundred and twenty-eight isolates of Salmonella Typhi were recovered from 2230 specimens. Resistanceby disk diffusion technique was 72% for ampicillin, 41.2% for cotrimoxazole, 38% for chloramphenicol, 8% for ciprofloxacin, 4.7% for cefpodoxime, 3.5% each for ertapenem aztreonam and moxifloxacin 2.4% for ceftriaxone and 2.3% for doripenem. No resistance was noted for imipenem, cefepime and gatifloxacin. Imipenem MIC90 was 0.38 and MIC50 was 0.25. For cefpirome, MIC90 was 0.64 and MIC50 was 0.09. For aztreonam, MIC90 was 0.12 and MIC50 was 0.09. Forcefpodoxime MIC90 was 0.75 and MIC50 was 0.38. For azithromycin, these values were 16.0 and 7.0; and for tigecycline they were 0.25 and 0.09. Conclusion: Imipenem, azithromycin, tigecycline, aztreonam, cefpodoxime and cefpirome are potential therapeutic agents for resistant Salmonella Typhi infection 
Publication Details
Page(s) 288-292
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 4, Year: 2016

Request the full text from PASTIC

Keywords
Resistance. Salmonella Typhi. Antibiotics. Cephalosporins
References
OchiaiRL,AcostaCJ,Danovaro-HollidayMC,BaiqingD,BhattacharyaSK,AgtiniMD, 2008.A study of typhoid fever in five Asian countries: disease burden and implications for controls,Bull World Health Organ 86 260 -8
MirzaSH,BeechingNJ, 1995.The prevalence and clinical features of multi-drug resistant Salmonella Typhi infections in Baluchistan, Pakistan,Ann Trop Med Parasitol 89 515 -9
MerminJH,TownesJM,GerberM,DolanN,MintzED,TauxeRV, 1998.changing risks of international travel and increasing antimicrobial resistance,Arch Intern Med 158 633 -8
GordonMA,KankwatiraAM,MwafulirwaG,WalshAL,HopkinsMJ,ParryCM, 2010.Invasive non-typhoid Salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis,Clin Infect Dis 50 953 -62
KoulPB,MuraliMV,SharmaPP,GhaiOP,RamchandranVG,TalwarV., 1991.Multi-drug resistant Salmonella Typhi infection: clinical profile and therapy,Indian Pediatr 28 357 -61
MirzaSH,BeechingNJ, 1996.Multi-drug resistant typhoid: a global problem,J Med Microbiol 44 317 -9
ParryCM,HienTT,DouganG,WhiteNJ,FarrarJJ, 2002.Typhoid fever,N Engl J Med 347 1770 -82
TarrPE,KuppensL,JonesTC,IvanoffB,AparinPG,HeymannDL, 1999.Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan,Am J Trop Med Hyg 61 163 -70
EllenJo,Baron,B ThomsonJr, 2012.Specimen collection, transport and processing: bacteriology,Manual of clinical microbiology 228 -71
WautersG,VaneechoutteM.,VersalovicJ,KarrollKC,FunkeG,JorgensonJH,LandryML, 2012.Approaches to the identification of aerobic gram-negative bacteria,Manual of clinical microbiology 539 -58
Grimont, 2007.Antigenic formulae of the Salmonella serovars, -
CLSI, 2012.Performance standards for antimicrobial susceptibility testing; twenty-second informational suppliment,M100-S22 -
ButlerT., 2001.Effect of increased inoculum of Salmonella Typhi on MIC of azithromycin and resultant growth characteristics,J Antimicrob Chemother 48 903 -6
2013.Ref type: Online Source,Version 3 -
QaiserS,IrfanS,KhanE,AhsanT,ZafarA., 2011.In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: a search for alternate treatment options,J Pak Med Assoc 61 462 -5
ChinhNT,ParryCM,LyNT,HaHD,ThongMX,DiepTS, 2000.A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acidresistant enteric fever,Antimicrob Agents Chemother 44 1855 -9
FrenckRW,Jr.,NakhlaI,SultanY,BassilySB,GirgisYF,DavidJ, 2000.Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children,Clin Infect Dis 31 1134 -8
ShanahanPM,KaramatKA,ThomsonCJ,AmyesSG, 2000.Characterization of multi-drug resistant Salmonella Typhi isolated from Pakistan,Epidemiol Infect 124 9 -16
MohantyS,RenukaK,SoodS,DasBK,KapilA, .Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital,Epidemiol Infect 134 961 -6
ArletG,BarrettTJ,ButayeP,CloeckaertA,MulveyMR,WhiteDG, 2006.Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology,Microbes Infect 8 1945 -54
2010.National antimicrobial resistance monitoring system for enteric bacteria (NARMS): Human isolates final report, -
Atlanta , Georgia: US Department of Health and Human,Services, 2010.Ref type: Pamphlet., -
MirzaSH,BeechingNJ, 1996.Multi-drug resistant typhoid: a global problem,J Med Microbiol 44 317 -9
AlNN,ZwartB,RijnsburgerMC,RoosendaalR,DebetsOssenkoppYJ,MulderJA, 2008.Extended-spectrum-betalactamase production in a Salmonella enterica serotype Typhi strain from the Philippines,J Clin Microbiol 46 2794 -5
0

Citations

0

Downloads

88

Views